2019
Setting ambitious targets for surveillance and treatment rates among patients with hepatitis C related cirrhosis impacts the cost-effectiveness of hepatocellular cancer surveillance and substantially increases life expectancy: A modeling study
Uyei J, Taddei TH, Kaplan DE, Chapko M, Stevens ER, Braithwaite RS. Setting ambitious targets for surveillance and treatment rates among patients with hepatitis C related cirrhosis impacts the cost-effectiveness of hepatocellular cancer surveillance and substantially increases life expectancy: A modeling study. PLOS ONE 2019, 14: e0221614. PMID: 31449554, PMCID: PMC6709904, DOI: 10.1371/journal.pone.0221614.Peer-Reviewed Original ResearchConceptsIncremental cost-effectiveness ratioCost-effectiveness ratioHCC treatmentLife expectancyDifferent surveillance intervalsDecision-analytic Markov modelHepatitis C virusCause of deathAspirational scenarioCurrent HCVHCC surveillanceHCC incidenceHepatitis CSurveillance intervalsC virusCancer surveillanceVeteran outcomesLower incidenceStudy groupHCVTreatment useCirrhosisEpidemiologic studiesPatientsCompliance rate
2012
Exploring beyond cirrhosis
Pinzani M, Groszmann R, Iwakiri Y, Taddei T. Exploring beyond cirrhosis. Hepatology 2012, 56: 778-780. PMID: 22833249, DOI: 10.1002/hep.25775.Peer-Reviewed Original ResearchChronic liver diseaseLiver diseaseComplications of portal hypertensionNatural history of cirrhosisHistory of cirrhosisStage of chronic liver diseaseTreatment of chronic liver diseaseAdvanced stage of chronic liver diseaseGrade of activityAdverse prognosisPortal hypertensionLiver failureHepatocellular carcinomaClinicopathological assessmentStudy groupCirrhosisRisk factorsNatural historyDiseaseEnd stage